Sökning: WFRF:(Arthur Cecilia) > The potential of li...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 05700naa a2200625 4500 | |
001 | oai:DiVA.org:uu-524335 | |
003 | SwePub | |
008 | 240301s2024 | |||||||||||000 ||eng| | |
009 | oai:DiVA.org:liu-201333 | |
009 | oai:prod.swepub.kib.ki.se:238371226 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5243352 URI |
024 | 7 | a https://doi.org/10.1093/noajnl/vdae0082 DOI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-2013332 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:2383712262 URI |
040 | a (SwePub)uud (SwePub)liud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Krynina, Olhau Karolinska Institutet4 aut |
245 | 1 0 | a The potential of liquid biopsy for detection of the KIAA1549-BRAF fusion in circulating tumor DNA from children with pilocytic astrocytoma |
264 | 1 | b Oxford University Press,c 2024 |
338 | a electronic2 rdacarrier | |
500 | a Funding Agencies|Barncancerfonden/The Barncancerfonden; Swedish Childhood Tumor Biobank - Barncancerfonden/The Swedish Childhood Cancer Fund; National Genomics Infrastructure in Stockholm - Science for Life Laboratory; Knut and Alice Wallenberg Foundation; Swedish Research Council | |
520 | a BackgroundLow-grade gliomas (LGGs) represent children’s most prevalent central nervous system tumor, necessitating molecular profiling to diagnose and determine the most suitable treatment. Developing highly sensitive screening techniques for liquid biopsy samples is particularly beneficial, as it enables the early detection and molecular characterization of tumors with minimally invasive samples.MethodsWe examined CSF and plasma samples from patients with pilocytic astrocytoma (PA) using custom multiplexed droplet digital polymerase chain reaction (ddPCR) assays based on whole genome sequencing data. These assays included a screening test to analyze BRAF duplication and a targeted assay for the detection of patient-specific KIAA1549::BRAF fusion junction sequences or single nucleotide variants.ResultsOur findings revealed that 5 out of 13 individual cerebrospinal fluid (CSF) samples tested positive for circulating tumor DNA (ctDNA). Among these cases, 3 exhibited the KIAA1549::BRAF fusion, which was detected through copy number variation (CNV) analysis (n = 1) or a fusion-specific probe (n = 2), while 1 case each displayed the BRAF V600E mutation and the FGFR1 N577K mutation. Additionally, a quantitative analysis of cell-free DNA (cfDNA) concentrations in PA CSF samples showed that most cases had low cfDNA levels, below the limit of detection of our assay (<1.9 ng).ConclusionsWhile CNV analysis of CSF samples from LGGs still has some limitations, it has the potential to serve as a valuable complementary tool. Furthermore, it can also be multiplexed with other aberrations, for example, to the BRAF V600 test, to provide important insights into the molecular characteristics of LGGs. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Cancer och onkologi0 (SwePub)302032 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cancer and Oncology0 (SwePub)302032 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Medicinsk genetik0 (SwePub)301072 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Medical Genetics0 (SwePub)301072 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Neurologi0 (SwePub)302072 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Neurology0 (SwePub)302072 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Pediatrik0 (SwePub)302212 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Pediatrics0 (SwePub)302212 hsv//eng |
653 | a cerebrospinal fluid | |
653 | a cfDNA | |
653 | a ddPCR | |
653 | a KIAA1549::BRAF | |
653 | a pilocytic astrocytoma | |
700 | 1 | a Díaz de Ståhl, Teresitau Karolinska Institutet4 aut |
700 | 1 | a Jylhä, Ceciliau Karolinska Institutet4 aut |
700 | 1 | a Arthur, Ceciliau Karolinska Institutet4 aut |
700 | 1 | a Giraud, Geraldineu Uppsala universitet,Science for Life Laboratory, SciLifeLab,Neuroonkologi och neurodegeneration,Akademiska University Hospital, Uppsala, Sweden,Rudbeck Lab, Sweden; Akadem Univ Hosp, Sweden4 aut0 (Swepub:uu)gergi266 |
700 | 1 | a Nyman, Peru Linköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Centrum för medicinsk bildvetenskap och visualisering, CMIV,Region Östergötland, H.K.H. Kronprinsessan Victorias barn- och ungdomssjukhus4 aut0 (Swepub:liu)perny73 |
700 | 1 | a Fritzberg, Andersu Clin Pediat Falun Hosp, Daycare Unit Oncol & Hematol, Dalarna, Dalarna Region, Sweden.4 aut |
700 | 1 | a Sandgren, Johannau Karolinska Institutet4 aut |
700 | 1 | a Tham, Emmau Karolinska Institutet4 aut |
700 | 1 | a Sandvik, Ulrikau Karolinska Institutet4 aut |
710 | 2 | a Karolinska Institutetb Science for Life Laboratory, SciLifeLab4 org |
773 | 0 | t Neuro-Oncology Advancesd : Oxford University Pressg 6:1q 6:1x 2632-2498 |
856 | 4 | u https://doi.org/10.1093/noajnl/vdae008y Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1842027/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-524335 |
856 | 4 8 | u https://doi.org/10.1093/noajnl/vdae008 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-201333 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:238371226 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy